Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/05/067029
CTRI/2024/05/067029
Recruiting
Phase 2

tility of Intra-venous autologous bone marrow derived stem cells infusion in chronic stroke. A Paracrine signaling & h-NMR spectroscopy study

Indian Council of Medical Research0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: I60-I69- Cerebrovascular diseases

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: I60-I69- Cerebrovascular diseases
Sponsor
Indian Council of Medical Research
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients diagnosed with ischemic stroke within 1\.5 months to 1 year of index event
  • •2\. Age:18\-65 years
  • •3\. MRC of hand and wrist muscles between 1\-3\.
  • •4\. Brunnstrom stage (3\-5\)
  • •5\. Subjects/ care givers agreed in writing that they will be participating in clinical research, as viewed from the legal representative (patient).

Exclusion Criteria

  • •1\. Active Infection
  • •2\. Immunocompromised state history or laboratory results indicative of any significant cardiac, endocrine, hematologic, hepatic, renal, or other disorders
  • •3\. Neoplastic diseases ; malignancy
  • •4\. Autoimmune disorders
  • •5\. Immune\-compromised subjects
  • •6\. Progressive neurological worsening
  • •7\. Contraindication to MRI
  • •8\. Female patients with known pregnancy or at risk of pregnancy, positive urine pregnancy test at screening.
  • •9\. Any other reason that, in the opinion of the Principal Investigator, makes the participant
  • •unsuitable for participation in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Stem cells therapy for patients with acute ischemic stroke.
CTRI/2008/091/000046Department of Biotechnology Ministry of Science and Technology Government of India New Delhi120
Completed
Phase 1
Intravenous autologous bone marrow mononuclear cell transplantation for cerebral embolismcerebral embolism
JPRN-UMIN000001133ational Cerbral and Cardiovascular Center12
Completed
Phase 2
Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic StrokeAcute Stroke
NCT01501773Manipal Acunova Ltd.120
Completed
Not Applicable
Autologous bone marrow cells in patients with critical limb ischemia
ISRCTN16096154ational Institute of Heart and Vascular Diseases62
Completed
Not Applicable
Bone marrow stem cell transplantation in patients with decompensated liver cirrhosisDecompensated liver cirrhosisDigestive SystemChronic Liver Disease/Cirrhosis
ISRCTN16139487. Kipshidze Central University Hospital (Georgia)34